The rising burden of respiratory tract cancer in Asia medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Global biopharmaceutical company GlaxoSmithKline is scheduled to submit market approvals in China for about 15 new drugs and indications over the next three years and more than 20 clinical research projects will be conducted in the country, said a senior executive of the company.
/PRNewswire/ On March 29, 2023, Broncus Medical (02216.HK), a leader in precise interventional diagnosis and therapy of lung diseases in China, announced.
GUANGZHOU, Dec. 8 (Xinhua) The southern Chinese city of Guangzhou reported a low rate of severe COVID-19 infections in the recent flare-up, and few local cas